Repligen Stock Price To Sales

RGEN Stock

USD 167.05 0.74 0.44%

Repligen fundamentals help investors to digest information that contributes to Repligen's financial success or failures. It also enables traders to predict the movement of Repligen Stock. The fundamental analysis module provides a way to measure Repligen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Repligen stock.

		Last Reported	Projected for Next Year
	Price To Sales Ratio	15.68	10.04

As of the 5th of May 2024, Price To Sales Ratio is likely to drop to 10.04.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Repligen Company Price To Sales Analysis

Repligen's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

P/S

MV Per Share

Revenue Per Share

More About Price To Sales | All Equity Analysis

Current Repligen Price To Sales

14.99 X

Most of Repligen's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Repligen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Repligen Price To Sales Driver Correlations

Understanding the fundamental principles of building solid financial models for Repligen is extremely important. It helps to project a fair market value of Repligen Stock properly, considering its historical fundamentals such as Price To Sales. Since Repligen's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Repligen's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Repligen's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Accounts Payable	Short Term Debt	Short Term Investments	Common Stock	Property Plant Equipment	Long Term Debt	Current Deferred Revenue	Good Will	Intangible Assets	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Accumulated Depreciation	Long Term Debt Total	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.81	-0.38	0.93	0.97	0.97	0.99	0.86	0.49	0.12	0.78	0.94	0.96	0.83	0.97	0.97	0.89	0.97	0.62	-0.33	0.76	0.46	0.96	0.92	0.99
Total Stockholder Equity	0.81		0.01	0.83	0.85	0.87	0.77	0.71	0.23	-0.18	0.45	0.86	0.76	0.47	0.8	0.77	0.71	0.77	0.38	-0.13	0.47	-0.01	0.76	0.72	0.75
Net Debt	-0.38	0.01		-0.08	-0.3	-0.24	-0.46	-0.44	-0.48	0.18	-0.66	-0.09	-0.45	-0.6	-0.37	-0.41	-0.37	-0.46	-0.62	0.46	-0.58	-0.76	-0.39	-0.4	-0.49
Retained Earnings	0.93	0.83	-0.08		0.95	0.96	0.91	0.77	0.38	0.22	0.64	0.99	0.9	0.7	0.93	0.91	0.87	0.9	0.51	-0.25	0.65	0.24	0.9	0.83	0.88
Net Receivables	0.97	0.85	-0.3	0.95		0.98	0.97	0.91	0.55	0.13	0.79	0.96	0.97	0.82	0.98	0.98	0.92	0.97	0.67	-0.38	0.76	0.41	0.95	0.86	0.95
Total Liab	0.97	0.87	-0.24	0.96	0.98		0.97	0.83	0.38	0.04	0.74	0.97	0.96	0.72	0.98	0.97	0.91	0.97	0.63	-0.35	0.73	0.3	0.93	0.89	0.94
Total Current Assets	0.99	0.77	-0.46	0.91	0.97	0.97		0.87	0.51	0.07	0.84	0.92	0.99	0.84	0.98	0.99	0.93	0.99	0.71	-0.42	0.81	0.49	0.95	0.91	0.98
Accounts Payable	0.86	0.71	-0.44	0.77	0.91	0.83	0.87		0.72	0.18	0.81	0.79	0.87	0.88	0.88	0.87	0.79	0.87	0.72	-0.4	0.76	0.63	0.86	0.72	0.85
Short Term Debt	0.49	0.23	-0.48	0.38	0.55	0.38	0.51	0.72		0.47	0.57	0.4	0.55	0.81	0.48	0.49	0.45	0.5	0.41	-0.39	0.43	0.66	0.54	0.3	0.5
Short Term Investments	0.12	-0.18	0.18	0.22	0.13	0.04	0.07	0.18	0.47		0.08	0.2	0.04	0.37	0.05	0.04	0.04	0.02	-0.14	-0.08	0.01	0.37	0.18	0.02	0.09
Common Stock	0.78	0.45	-0.66	0.64	0.79	0.74	0.84	0.81	0.57	0.08		0.65	0.83	0.86	0.83	0.85	0.79	0.85	0.92	-0.57	0.92	0.7	0.84	0.8	0.79
Property Plant Equipment	0.94	0.86	-0.09	0.99	0.96	0.97	0.92	0.79	0.4	0.2	0.65		0.91	0.7	0.94	0.92	0.88	0.91	0.51	-0.28	0.65	0.23	0.91	0.84	0.9
Long Term Debt	0.96	0.76	-0.45	0.9	0.97	0.96	0.99	0.87	0.55	0.04	0.83	0.91		0.83	0.98	0.98	0.96	0.99	0.73	-0.41	0.83	0.45	0.93	0.86	0.95
Current Deferred Revenue	0.83	0.47	-0.6	0.7	0.82	0.72	0.84	0.88	0.81	0.37	0.86	0.7	0.83		0.8	0.81	0.74	0.82	0.67	-0.35	0.78	0.79	0.89	0.76	0.84
Good Will	0.97	0.8	-0.37	0.93	0.98	0.98	0.98	0.88	0.48	0.05	0.83	0.94	0.98	0.8		1.0	0.94	0.99	0.76	-0.41	0.8	0.43	0.93	0.87	0.95
Intangible Assets	0.97	0.77	-0.41	0.91	0.98	0.97	0.99	0.87	0.49	0.04	0.85	0.92	0.98	0.81	1.0		0.94	1.0	0.77	-0.42	0.81	0.45	0.93	0.88	0.96
Net Tangible Assets	0.89	0.71	-0.37	0.87	0.92	0.91	0.93	0.79	0.45	0.04	0.79	0.88	0.96	0.74	0.94	0.94		0.94	0.74	-0.41	0.86	0.36	0.86	0.79	0.88
Capital Surpluse	0.97	0.77	-0.46	0.9	0.97	0.97	0.99	0.87	0.5	0.02	0.85	0.91	0.99	0.82	0.99	1.0	0.94		0.76	-0.41	0.82	0.48	0.94	0.89	0.97
Deferred Long Term Liab	0.62	0.38	-0.62	0.51	0.67	0.63	0.71	0.72	0.41	-0.14	0.92	0.51	0.73	0.67	0.76	0.77	0.74	0.76		-0.52	0.88	0.59	0.65	0.61	0.64
Accumulated Depreciation	-0.33	-0.13	0.46	-0.25	-0.38	-0.35	-0.42	-0.4	-0.39	-0.08	-0.57	-0.28	-0.41	-0.35	-0.41	-0.42	-0.41	-0.41	-0.52		-0.42	-0.36	-0.3	-0.26	-0.34
Long Term Debt Total	0.76	0.47	-0.58	0.65	0.76	0.73	0.81	0.76	0.43	0.01	0.92	0.65	0.83	0.78	0.8	0.81	0.86	0.82	0.88	-0.42		0.61	0.81	0.78	0.77
Short Long Term Debt	0.46	-0.01	-0.76	0.24	0.41	0.3	0.49	0.63	0.66	0.37	0.7	0.23	0.45	0.79	0.43	0.45	0.36	0.48	0.59	-0.36	0.61		0.5	0.41	0.53
Net Invested Capital	0.96	0.76	-0.39	0.9	0.95	0.93	0.95	0.86	0.54	0.18	0.84	0.91	0.93	0.89	0.93	0.93	0.86	0.94	0.65	-0.3	0.81	0.5		0.95	0.94
Net Working Capital	0.92	0.72	-0.4	0.83	0.86	0.89	0.91	0.72	0.3	0.02	0.8	0.84	0.86	0.76	0.87	0.88	0.79	0.89	0.61	-0.26	0.78	0.41	0.95		0.91
Capital Stock	0.99	0.75	-0.49	0.88	0.95	0.94	0.98	0.85	0.5	0.09	0.79	0.9	0.95	0.84	0.95	0.96	0.88	0.97	0.64	-0.34	0.77	0.53	0.94	0.91

Click cells to compare fundamentals

Repligen Price To Sales Historical Pattern

Today, most investors in Repligen Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Repligen's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Repligen price to sales as a starting point in their analysis.

Repligen Price To Sales

Timeline

The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Competition

Predict Repligen

Price To Sales Ratio Over Time

Repligen Price To Sales Ratio

Price To Sales Ratio

10.04

At this time, Repligen's Price To Sales Ratio is very stable compared to the past year.

Based on the latest financial disclosure, Repligen has a Price To Sales of 14.9945 times. This is 29.93% lower than that of the Life Sciences Tools & Services sector and 40.57% lower than that of the Health Care industry. The price to sales for all United States stocks is 31.3% lower than that of the firm.

Repligen Price To Sales Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Repligen's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Repligen could also be used in its relative valuation, which is a method of valuing Repligen by comparing valuation metrics of similar companies.

Repligen is currently under evaluation in price to sales category among related companies.

Repligen Fundamentals

	Return On Equity	0.0076
	Return On Asset	0.006
	Profit Margin	0.02 %
	Operating Margin	0.01 %
	Current Valuation	9.29 B
	Shares Outstanding	55.88 M
	Shares Owned By Insiders	6.58 %
	Shares Owned By Institutions	93.42 %
	Number Of Shares Shorted	4.59 M
	Price To Earning	154.58 X
	Price To Book	4.86 X
	Price To Sales	14.99 X
	Revenue	638.76 M
	Gross Profit	455.71 M
	EBITDA	131.39 M
	Net Income	41.58 M
	Cash And Equivalents	596.51 M
	Cash Per Share	10.75 X
	Total Debt	711.8 M
	Debt To Equity	0.23 %
	Current Ratio	2.30 X
	Book Value Per Share	35.29 X
	Cash Flow From Operations	113.92 M
	Short Ratio	10.84 X
	Earnings Per Share	0.27 X
	Price To Earnings To Growth	2.59 X
	Target Price	204.58
	Number Of Employees	1.78 K
	Beta	1.01
	Market Capitalization	9.33 B
	Total Asset	2.82 B
	Retained Earnings	438.85 M
	Working Capital	952.88 M
	Current Asset	103.25 M
	Current Liabilities	18.78 M
	Net Asset	2.82 B

About Repligen Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Repligen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Repligen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Repligen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

BILI	Bilibili
S	SentinelOne
BAC	Bank of America
GM	General Motors
GOOG	Alphabet Inc Class C

When determining whether Repligen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Repligen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Repligen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Repligen Stock:

How To Invest In Repligen

Details

Is Repligen Stock a good investment?

Details

What is Repligen's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Repligen Piotroski F Score and Repligen Altman Z Score analysis.

To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.

Note that the Repligen information on this page should be used as a complementary analysis to other Repligen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for Repligen Stock analysis

When running Repligen's price analysis, check to measure Repligen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repligen is operating at the current time. Most of Repligen's value examination focuses on studying past and present price action to predict the probability of Repligen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repligen's price. Additionally, you may evaluate how the addition of Repligen to your portfolios can decrease your overall portfolio volatility.

	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	CEOs Directory Screen CEOs from public companies around the world
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments

Is Repligen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.93)

Earnings Share

0.27

Revenue Per Share

10.892

Quarterly Revenue Growth

(0.17)

Return On Assets

0.006

The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Repligen Stock Price To Sales

Repligen Company Price To Sales Analysis

P/S

MV Per Share

Revenue Per Share

Current Repligen Price To Sales

Repligen Price To Sales Driver Correlations

Repligen Price To Sales Historical Pattern

Repligen Price To Sales Ratio

Price To Sales Ratio

10.04

Repligen Price To Sales Peer Comparison

Repligen Fundamentals

About Repligen Fundamental Analysis

Currently Active Assets on Macroaxis

Complementary Tools for Repligen Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY